Literature DB >> 35048353

Atypical manifestations of infantile-onset nephropathic cystinosis: a diagnostic challenge.

Bobbity Deepthi1, Sriram Krishnamurthy2, Pediredla Karunakar1, Gowrishankar Barathidasan1, Thiagarajan Narayanasamy Rajavelu1.   

Abstract

A 7-month-old male infant was referred to us for evaluation of hypercalcemia and failure to thrive. He was the second-born child to third-degree consanguineous parents with a birth weight of 3.5 kg. The index child was severely underweight. Initial laboratory investigations showed hypercalcemia (13.6 mg/dL), hypophosphatemia, hyponatremia, hypokalemia and hypochloremia. The initial serum bicarbonate level was 20.9 mEq/L. The urine calcium: creatinine ratio (0.05) was normal. He was noted to have polyuria (6 mL/kg/hr) and required intravenous fluids to maintain intravascular volume and manage hypercalcemia, along with potassium chloride supplements. The serum calcium decreased to 9.7 mg/dL after hydration for 48 h. At this juncture, the child was noted to exhibit metabolic acidosis (serum bicarbonate 16 mEq/L) for the first time. Thereafter, fractional excretion of bicarbonate was estimated to be 16.5% while the tubular threshold maximum for phosphorus per glomerular filtration rate was 1.2 mg/dL; indicating bicarbonaturia and phosphaturia, respectively. Glycosuria with aminoaciduria were also noted. Clinical exome sequencing revealed a NM_004937.3:c.809_811del in exon 10 of the CTNS gene that resulted in in-frame deletion of amino acids [NP_004928.2:p.Ser270del] at the protein level. The child is now growing well on oral potassium citrate, neutral phosphate and sodium bicarbonate supplements. This case was notable for absence of metabolic acidosis at admission. Instead, severe hypercalcemia was a striking presenting manifestation, that has not been reported previously in literature. Cystinosis has been earlier described in association with metabolic acidosis, hypocalcemia and hypomagnesemia. However, typical features like metabolic acidosis were masked in early stages of the disease in our case posing a diagnostic challenge. This atypical initial presentation adds to the constellation of clinical features in this condition.
© 2021. Japanese Society of Nephrology.

Entities:  

Keywords:  CTNS gene; Cystinosis; Hypercalcemia; Hypophosphatemia; Metabolic acidosis; Polyuria

Mesh:

Substances:

Year:  2022        PMID: 35048353      PMCID: PMC9343515          DOI: 10.1007/s13730-021-00675-x

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  22 in total

1.  Clinical utility gene card for: cystinosis.

Authors:  Elena Levtchenko; Lambertus van den Heuvel; Francesco Emma; Corinne Antignac
Journal:  Eur J Hum Genet       Date:  2013-09-18       Impact factor: 4.246

2.  Course of nephropathic cystinosis after age 10 years.

Authors:  W A Gahl; J A Schneider; J G Thoene; R Chesney
Journal:  J Pediatr       Date:  1986-10       Impact factor: 4.406

3.  Growth retardation in children with cystinosis.

Authors:  M Besouw; E Levtchenko
Journal:  Minerva Pediatr       Date:  2010-06       Impact factor: 1.312

4.  Inflammasome activation by cystine crystals: implications for the pathogenesis of cystinosis.

Authors:  Giusi Prencipe; Ivan Caiello; Stephanie Cherqui; Thomas Whisenant; Stefania Petrini; Francesco Emma; Fabrizio De Benedetti
Journal:  J Am Soc Nephrol       Date:  2014-02-13       Impact factor: 10.121

5.  Gastrointestinal manifestations of nephropathic cystinosis in children.

Authors:  Shahrbanoo Nakhaii; Nakysa Hooman; Hasan Otukesh
Journal:  Iran J Kidney Dis       Date:  2009-10       Impact factor: 0.892

6.  Report of a Brazilian multicenter study on nephropathic cystinosis.

Authors:  Maria Helena Vaisbich; Vera H Koch
Journal:  Nephron Clin Pract       Date:  2009-10-09

7.  Cystinosis in the Federal Republic of Germany. Coordination and analysis of the data.

Authors:  F Manz; N Gretz
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

Review 8.  Cystinosis: a review.

Authors:  Mohamed A Elmonem; Koenraad R Veys; Neveen A Soliman; Maria van Dyck; Lambertus P van den Heuvel; Elena Levtchenko
Journal:  Orphanet J Rare Dis       Date:  2016-04-22       Impact factor: 4.123

Review 9.  Effects of long-term cysteamine treatment in patients with cystinosis.

Authors:  Gema Ariceta; Vincenzo Giordano; Fernando Santos
Journal:  Pediatr Nephrol       Date:  2017-12-19       Impact factor: 3.714

Review 10.  Physiological regulation of phosphate by vitamin D, parathyroid hormone (PTH) and phosphate (Pi).

Authors:  Grégory Jacquillet; Robert J Unwin
Journal:  Pflugers Arch       Date:  2018-11-05       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.